Our vision

We assess the pharmacological behavior of your molecules

in a rational stage-by-stage manner to direct them towards

the right disease indication and the right patient targets.

 

 

READ MORE

Optimize your clinical drug development
with pharmaco-imaging biomarkers

Our pharmacology and model expertise combined with

multi-parametric imaging to support clinical development.

 

 

READ MORE

We set the industrial standard for
relevant models

Design of patient-derived xenografts and human

immune system models to evaluate your drugs in

clinically-relevant conditions.

 

READ MORE

We kick off kinase inhibitors
on the right track

Highly potent and selective leads for both well-established

and unexplored kinases, along with Oncodesign's integrated

drug discovery approach.

 

READ MORE

We create synergies to advance
cancer research

Oncodesign is leader in long-term collaborative research projects

to join forces against cancer and progress towards personalized

medecine.

 

March 31 - April 4, 2012
AACR Annual Meeting 2012. Chicago, IL
READ MORE
January 5, 2012
Oncodesign and Ipsen enter into a research collaboration against the LRRK2 Parkinson's disease
READ MORE

ONCOLOGY TRANSLATIONAL

EXPERIMENTATION

A large panel of technological and scientific solutions for pharmacological qualification of your compounds : a unique oncology preclinical CRO

DISCOVERY PARTNERING

 

A platform-based approach for the discovery of novel chemical entities with therapeutic and diagnostic potential